Article

FIB-4: a screening tool for advanced liver fibrosis in a cohort of subjects participating in a primary care weight-loss program

2024-12-13

Abstract excerpt

<title>Abstract</title> <p>Systematic screening for liver fibrosis using FIB-4 score is recommended in primary care for patients with chronic liver disease risk factors. This study assesses the prevalence and characteristics of patients at risk for advanced fibrosis in a weight loss program. This multicenter retrospective cohort study includes obese and overweight subjects participating in a weight loss program a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 71919cee-79c2-5ba6-b86b-b613e1cbd91c
DOI: 10.21203/rs.3.rs-5368153/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

FIB-4: a screening tool for advanced liver fibrosis in a cohort of subjects participating in a primary care weight-loss programDOI 10.21203/rs.3.rs-5368153/v1Read

Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver diseaseSemantic proximity Read

Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver diseaseSemantic proximity Read

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read

Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients With MASLD: Results From the OBREDI-TR StudySemantic proximity Read

Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver DiseaseSemantic proximity Read

Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control studySemantic proximity Read

Age-stratified Analysis of Associations Between Participant’s Characteristics and NAFLDSemantic proximity Read

Metabolic and Clinical Heterogeneity in MASLD Risk Stratification: Independent Effects of Body Mass Index and Fib-4 on Cirrhosis, and Clinical Implications of Noninvasive Score Discordance in a Veteran CohortSemantic proximity Read

[Progress in the study of nonalcoholic fatty liver disease: insights from research in 2013].Semantic proximity Read

FGF21 reflects a responsive adipose tissue-liver axis in both cardiometabolic burden and following metabolic surgerySemantic proximity Read

Metabolic and hepatic phenotypes in sarcopenic obesity and impact of bariatric surgery.Semantic proximity Read

Obesity-associated nonalcoholic fatty liver disease.Semantic proximity Read